Navigation Links
Health Diagnostic Laboratory Names Scott Blackwell Vice President of Corporate Culture
Date:4/3/2012

RICHMOND, Va., April 3, 2012 /PRNewswire/ -- Health Diagnostic Laboratory, Inc. (HDL, Inc.), a leader in health management, has announced the hiring of Scott Blackwell. Recently named Vice President of Corporate Culture, Blackwell will oversee the unique culture, vision, and values of an advanced laboratory that is growing on average of 5-8% per week.

(Photo:  http://photos.prnewswire.com/prnh/20120403/PH81634

"Scott comes to our lab with over 15 years of experience in human resources as a senior executive. His track record speaks volumes – he clearly knows how to attract, retain, and energize the best professionals in the business," said Tonya Mallory, co-founder and CEO of HDL, Inc.

Blackwell, who holds a Senior Professional in Human Resources (SPHR) certification, attended Senior Human Resources Management programs at Cornell University and the Center for Creative Leadership. He holds a degree from the University of Virginia.  He holds multiple board positions, such as Chair-Elect of Leadership Metro Richmond, Art 180, and 1708 Gallery.

"Joining a young and thriving organization like HDL, Inc. provides an opportunity to continue to bolster the corporate culture inside a company that is proving to be a hotbed of medical advancements, productivity, and community giving," said Blackwell. 

Blackwell joins the company on the heels of HDL, Inc. receiving the 2012 Best Places to Work award by Virginia Business magazine. He will become part of a team, based at the Virginia Biotechnology Research Park, undergoing a growth period that will see an additional 353 new jobs during Phase 1 of a $38.5 million expansion, followed by 300 additional new jobs in Phase 2.

"HDL, Inc. is redefining the way clinical laboratories interact with physicians and patients. I'm proud to be part of a company, and a medical community at large, that has the ability to save lives thanks to advanced testing," said Blackwell.

About HDL, Inc. 

Health Diagnostic Laboratory Inc. (HDL, Inc.), a CAP accredited leader in health management, offers a comprehensive test menu of risk factors and biomarkers for cardiovascular and related diseases. Our systematic approach identifies factors contributing to disease and provides a basis for effective treatment, allowing physicians to more effectively manage patients.  As an added value, patients receive a personalized overview of their risk factors along with intensive counseling from expert Health Coaches at no additional cost, improving compliance and enhancing satisfaction.


'/>"/>
SOURCE HDL, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. PharmAthene Secures $7.5 Million Credit Facility From GE Capital, Healthcare Financial Services
2. Regado Biosciences, Inc. to Present at Needham & Companys 11th Annual Healthcare Conference in New York, NY
3. All Global Partners With HealthEngage to Provide Unique Web 2.0 Patient Insights
4. Elsevier Collaborates With Prophecy Healthcare to Enhance Its Staff Development Offerings for Healthcare Organizations
5. Providence Health & Services Inks Deal with Remedy Informatics for Orthopedic and Stroke Registries
6. Foundation for Health Improvement and Technology (FHIT) Launched to Beat Cardiovascular Disease
7. Conflict of Interest Management System Selected by Via Christi Health
8. Good Shepherd Rehabilitation Network Becomes Third Health-Care Organization in U.S. to Have Ekso Exoskeleton
9. Interim Clinical Trial Results Confirm Safety of Renadyl™, a Probiotic Dietary Supplement for the Support of Healthy Kidney Function
10. Camelot Healthcare Training Institute Acquired by Medtech
11. Receptos to Present at the Cowen and Company 32nd Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... 27, 2017 Four US Biotech ... today, and they are: Anthera Pharmaceuticals Inc. (NASDAQ: ANTH), ... Inc. (NASDAQ: PACB), and Conatus Pharmaceuticals Inc. (NASDAQ: ... Trends, market observers are growing more bullish on the ... reforms to free cash held overseas for tax reason ...
(Date:2/27/2017)... , ... February 27, 2017 , ... The Catalyst ... a few in the Midwest offering premix services and private label organic services. , ... laying hens, according Jos Zamzow, chief operating officer of Dynamite Marketing, which owns the ...
(Date:2/24/2017)... ... ... Delpor, Inc. (Delpor), a biotechnology company focused on drug delivery, today announced ... for the further advancement of the company’s 3-month olanzapine product ( DLP-119 ). The ... therapeutic levels of olanzapine for a period of 3 months., “We are honored and ...
(Date:2/24/2017)... SAN FRANCISCO , Feb. 24, 2017 ... that is developing a new category of therapeutics, announced ... trial of SB-030 in peripheral artery disease. The trial ... locally administered single-use therapeutic, in the reduction of restenosis ... reached this critical development milestone for SB-030," said ...
Breaking Biology Technology:
(Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis zum Jahr 2018 ... mehr als 50 Vertretern aus verschiedenen Branchen wurde aber klar, ... Prognose zu realisieren. ... Zu den Schwierigkeiten für Biobanking-Profis ... die Biobank, die Implementierung Zeit sparender Technologien, ein besseres ...
(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
(Date:2/8/2017)... 2017 The biometrics market has reached ... of organizations, desires to better authenticate or identify ... and challenge questions), biometrics is quickly working its ... market is driven by use cases, though there ... enterprise uses cases, with consumer-facing use cases encompassing ...
Breaking Biology News(10 mins):